PLN and familial dilated cardiomyopathy: In another study, Barndt et al. (2021) generated PLN-R9C induced pluripotent stem cells (iPSCs), a new disease model using CRISPR/Cas9 single nucleotide editing technology, for studying the molecular mechanisms underlying phospholamban (PLN) mutation-related DCM [65].